Sign in to view content

Efficacy of Intravitreal Pegcetacoplan in Geographic Atrophy: Results from the Phase 3 DERBY and OAKS Trials

Nathan C. Steinle, MD

Video
Published 2021

Related

Association Between Dysfunctional Complement Factor I: Rare Variant Status and Progression to Advanced AMD Outcomes
Johanna M. Seddon, MD, ScM, FARVO, FASRS
Annual Meeting Talks
2022
Twelve Month Safety and Efficacy Outcomes from a Phase 2 Study of APL-2 in Patients with Geographic Atrophy
David S. Boyer, MD
Updates from the Field
2017
Pegcetacoplan Safety: Panel Recap
Andre J. Witkin, MD
Updates from the Field
2024

Category: AMD-Non-Neovascular

See more